Inversion Transactions

In a report published Wednesday, Barclays analyst Douglas Tsao detailed why he believes that M&A activity within the Specialty Pharmaceutical sector is expected to continue. According to Tsao, much of the consolidation seen in the industry has been driven by "strategic considerations" rather...